Clinical evaluation of kallikrein in male infertility

Kallikrein was orally administered to 44 patients with male infertility at a dose of 90 or 120 KU/day for three months. The sperm density, sperm motility and fertility index (F.I.) were improved in 51.1%, 37.2% and 38.9% of the treated patients, respectively. Statistical analysis showed that signifi...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 32(1986), 9 vom: 16. Sept., Seite 1313-8
1. Verfasser: Takasaki, N (VerfasserIn)
Weitere Verfasser: Ogita, T, Tonami, H, Shimizu, A, Ueno, N, Okano, H
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1986
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Kallikreins EC 3.4.21.-
Beschreibung
Zusammenfassung:Kallikrein was orally administered to 44 patients with male infertility at a dose of 90 or 120 KU/day for three months. The sperm density, sperm motility and fertility index (F.I.) were improved in 51.1%, 37.2% and 38.9% of the treated patients, respectively. Statistical analysis showed that significant improvement was noted in sperm density and F.I. between before and after the treatment, but not in sperm motility, sperm volume nor sperm morphology. During the period of treatment, in these treated 44 patients, 4 patients (9.1%) succeeded in pregnancy
Beschreibung:Date Completed 04.03.1987
Date Revised 15.11.2007
published: Print
Citation Status MEDLINE
ISSN:0018-1994